Awake Craniotomy Surgery in Hyderabad
Precise brain tumour removal while you are conscious — preserving speech, movement, and cognition through intraoperative cortical mapping. Performed by Dr. Sayuj Krishnan at Yashoda Hospital, Malakpet.
What is Awake Craniotomy?
An awake craniotomy is a specialised neurosurgical technique in which the patient is kept conscious during critical phases of brain surgery. The term "craniotomy" refers to the temporary removal of a section of skull bone to access the brain. During the awake phase, the neurosurgeon uses direct electrical stimulation to create a real-time functional map of the brain, identifying areas responsible for speech, language, motor control, sensory perception, and other vital functions.
This technique is particularly valuable when a brain tumour lies in or near eloquent cortex— the regions of the brain that control functions you use every day: speaking, understanding language, moving your arms and legs, or processing sensory information. Because every individual's brain organisation is unique, preoperative imaging alone cannot definitively predict where these functions reside. Awake craniotomy provides the neurosurgeon with a live, patient-specific map that no imaging technology can replicate.
The goal is maximal safe resection: removing as much tumour as possible while preserving the patient's neurological function and quality of life. Multiple studies published in leading neurosurgical journals have demonstrated that awake craniotomy with brain mapping achieves higher rates of complete tumour removal and lower rates of postoperative neurological deficits compared to conventional surgery under general anaesthesia for tumours in eloquent areas.
When is Awake Craniotomy Recommended?
Awake craniotomy is not required for every brain operation. It is specifically indicated when the surgical target lies near areas critical for neurological function.
Brain Tumours Near Eloquent Areas
Gliomas (low-grade and high-grade), metastases, or meningiomas located adjacent to Broca's area (speech production), Wernicke's area (language comprehension), the primary motor cortex, sensory cortex, or along critical white matter tracts such as the arcuate fasciculus or corticospinal tract.
Brain tumour surgery→Epilepsy Surgery
When the epileptogenic zone (seizure focus) is located in or near eloquent cortex, awake craniotomy allows the surgeon to map function before resecting the seizure focus. This is especially relevant for temporal lobe epilepsy with language lateralisation concerns and extratemporal epilepsy near the motor strip.
Epilepsy surgery→Functional Cortical Mapping
Some patients require awake surgery specifically for electrocorticography (ECoG) and cortical stimulation mapping to delineate the boundaries of functional cortex, even when the primary pathology is not immediately adjacent. This is common in recurrent tumours where prior surgery may have shifted functional anatomy.
Read our detailed guide→The Awake Craniotomy Procedure: Step by Step
Preoperative Planning and Imaging
Before surgery, the team obtains high-resolution MRI sequences, functional MRI (fMRI) to localise speech and motor activation, and diffusion tensor imaging (DTI/tractography) to visualise critical white matter pathways. A neuropsychological baseline assessment documents the patient's language, memory, and cognitive function. These data are loaded into the neuronavigation system to create a three-dimensional surgical plan.
Anaesthesia and Scalp Block
On the day of surgery, the anaesthesia team administers a scalp nerve block — local anaesthetic injections along the nerves supplying the scalp — to ensure complete numbness of the surgical site. The most common protocol is the asleep-awake-asleep technique: the patient is sedated during the craniotomy opening and wound closure, and awakened only during the mapping and tumour resection phase. This minimises anxiety and discomfort.
Craniotomy and Brain Exposure
While the patient is sedated, the surgeon makes a scalp incision and removes a bone flap to expose the area of brain overlying the tumour. The dura mater (the membrane covering the brain) is opened carefully. The neuronavigation system confirms the planned trajectory aligns with the patient's anatomy.
Awake Phase: Cortical and Subcortical Mapping
Sedation is reduced and the patient is gently awakened. A neuropsychologist or speech therapist guides the patient through a series of tasks: naming pictures, counting, reading aloud, moving fingers and toes, and identifying sensations. Meanwhile, the neurosurgeon applies a small electrical current (direct electrical stimulation, or DES) to different points on the brain surface and deeper structures. If stimulation of a specific point disrupts speech or causes involuntary movement, that area is marked as functionally critical and preserved.
Tumour Resection Under Continuous Monitoring
With the functional map established, the surgeon begins removing the tumour. Resection proceeds methodically, with repeated stimulation and patient testing to ensure that the boundary between tumour and functional tissue is respected. Intraoperative ultrasound or neuronavigation updates help track the resection progress. The goal is to remove as much tumour as safely possible while maintaining neurological integrity.
Closure and Postoperative Care
Once tumour removal is complete, the patient is re-sedated. The bone flap is secured back in place with titanium plates, and the scalp is closed in layers. The patient is transferred to the neuro-ICU for overnight monitoring. An MRI is typically performed within 48 hours to assess the extent of resection and check for any early complications.
Brain Mapping During Surgery
Intraoperative brain mapping is the cornerstone of awake craniotomy. It transforms surgery from a purely image-guided procedure into a functionally guided one, providing information that no preoperative scan can deliver with the same precision.
Language Mapping
The patient is asked to name objects, repeat sentences, read words, and generate verbs while the surgeon stimulates cortical and subcortical sites. Disruptions such as speech arrest (sudden inability to speak), paraphasia (substituting wrong words), or anomia (inability to name an object) identify critical language pathways. Both Broca's area (speech production) and Wernicke's area (comprehension) are tested systematically.
Motor Mapping
Stimulation of the primary motor cortex produces involuntary muscle contractions in the contralateral (opposite side) face, arm, or leg. Subcortical stimulation along the corticospinal tract can also elicit motor responses. The patient is simultaneously asked to perform voluntary movements — squeezing a ball, tapping fingers, wiggling toes — to detect any subtle weakness that stimulation near motor pathways may cause.
Sensory and Cognitive Testing
Beyond speech and movement, the team assesses other functions depending on the tumour location. This may include visual field testing (for tumours near the occipital cortex or optic radiation), reading and writing (for dominant hemisphere lesions), calculation tasks, spatial awareness (for non-dominant hemisphere tumours), and memory testing. This comprehensive approach ensures that the surgical plan accounts for all neurological functions at risk.
Benefits of Awake Craniotomy
Awake craniotomy with intraoperative mapping offers significant advantages over conventional brain surgery under general anaesthesia, particularly for tumours in eloquent brain regions.
Maximal Safe Resection
Real-time functional feedback allows the surgeon to push resection boundaries further than would be safe with imaging guidance alone. Studies consistently show that awake craniotomy achieves gross total resection in 70-90% of eloquent-area gliomas, compared with 50-60% under general anaesthesia. Greater extent of resection is associated with longer survival and delayed tumour recurrence.
Preserved Neurological Function
The rate of new permanent neurological deficit following awake craniotomy is 2-4%, compared with 8-15% in published series without intraoperative mapping. Preserving speech, motor function, and cognition directly impacts quality of life, ability to work, and independence after surgery.
Individualised Functional Map
Every brain is organised differently. Functional MRI provides approximate localisation, but direct cortical stimulation is the gold standard for identifying where critical functions reside in an individual patient. This is especially important in patients with tumours that may have displaced or reorganised functional cortex over time.
Better Oncological Outcomes
For gliomas, greater extent of resection achieved through awake craniotomy translates to improved progression-free survival and overall survival. A landmark 2011 study in The Lancet Oncology showed that patients who underwent awake surgery for low-grade gliomas had significantly better survival outcomes than those who had biopsy or subtotal resection alone.
Recovery After Awake Craniotomy
Recovery from awake craniotomy follows a structured pathway designed to monitor neurological function closely in the immediate postoperative period and support gradual return to normal activities.
First 24 Hours
The patient is monitored in the neuro-intensive care unit with regular neurological assessments (speech, motor strength, pupil reactions) performed every one to two hours. Mild headache and fatigue are expected. Most patients can eat, drink, and sit up within a few hours of surgery.
Days 2-5 (Hospital Stay)
Transfer to the neurosurgery ward. A postoperative MRI is obtained, usually within 48 hours, to confirm the extent of tumour removal and rule out complications such as haematoma or infarction. Physiotherapy and speech therapy assessments begin if any deficits are noted. Surgical wound care and pain management are optimised.
Weeks 1-4 (Early Recovery)
Most patients can manage light activities at home within the first week. Driving is typically restricted for 4-6 weeks. Temporary speech difficulties or mild weakness, if present, often improve significantly during this period as brain swelling resolves. A follow-up appointment at 2 weeks includes wound check and preliminary discussion of histopathology results.
Weeks 4-12 (Return to Function)
Depending on the histological diagnosis, adjuvant treatment (radiotherapy, chemotherapy, or both) may begin 3-4 weeks after surgery. Return to work is generally possible within 4-6 weeks for desk-based employment and 8-12 weeks for physically demanding roles. Neuropsychological reassessment at 3 months documents cognitive recovery.
Risks and Safety
As with any cranial surgery, awake craniotomy carries risks. A transparent discussion of these risks is an essential part of informed consent and surgical planning. Dr. Sayuj Krishnan discusses all potential risks and benefits during the preoperative consultation.
Risk Profile of Awake Craniotomy
| Risk | Approximate Rate | Management |
|---|---|---|
| Intraoperative seizure | 2-5% | Immediately controlled with cold saline irrigation or short-acting anticonvulsant |
| Transient neurological deficit | 5-15% | Most resolve within days to weeks as brain swelling subsides; speech therapy and physiotherapy support recovery |
| Permanent neurological deficit | 2-4% | Significantly lower than 8-15% seen without intraoperative mapping |
| Surgical site infection | 1-2% | Prophylactic antibiotics; meticulous sterile technique |
| Postoperative haematoma | 1-2% | Close monitoring in neuro-ICU; re-exploration if clinically significant |
| Conversion to general anaesthesia | ~2% | If patient cannot cooperate; surgery continues safely under GA |
Have Questions About Awake Craniotomy?
Dr. Sayuj Krishnan provides personalised consultations to evaluate whether awake craniotomy is the right approach for your condition.
Why Choose Dr. Sayuj Krishnan for Awake Craniotomy in Hyderabad
Awake craniotomy demands a neurosurgeon with specific training and experience in intraoperative brain mapping, supported by a multidisciplinary team. Dr. Sayuj Krishnan brings a combination of international fellowship training, advanced technology, and a patient-centred approach to every case.
German Fellowship Training
Dr. Sayuj Krishnan completed advanced neurosurgical training in Germany, gaining hands-on experience in awake craniotomy techniques, intraoperative neurophysiological monitoring, and neuronavigation-guided tumour resection at high-volume academic centres.
Multimodal Mapping Approach
Every awake craniotomy case benefits from a combination of preoperative functional MRI, diffusion tensor imaging for white matter tract visualisation, intraoperative neuronavigation, and direct electrical stimulation. This multimodal approach provides multiple layers of safety during tumour resection.
Dedicated Neuro-Anaesthesia Team
Awake craniotomy requires an anaesthesiologist experienced in the asleep-awake-asleep technique, skilled in managing patient comfort and airway during the conscious phase. Yashoda Hospital's neuro-anaesthesia team has extensive experience with awake neurosurgical procedures.
Comprehensive Neuro-Oncology Support
From preoperative tumour board discussions through to postoperative adjuvant therapy planning, patients receive coordinated care involving neurosurgery, neuro-oncology, radiation oncology, neuropathology, and neurorehabilitation — ensuring that surgery is one part of a complete treatment strategy.
Awake Craniotomy Surgery FAQs
About the Procedure
Indications
Procedure
Patient Experience
Recovery
Safety
Outcomes
Cost
Why Dr. Sayuj
Is Awake Craniotomy Right for You?
If you or a family member has been diagnosed with a brain tumour near speech or motor areas, an awake craniotomy may offer the best chance of complete tumour removal while preserving neurological function. Book a consultation with Dr. Sayuj Krishnan to discuss your options.